Purpose of this Study
We are doing this study to support vaccine development by studying blood cells of the immune system.
Who Can Participate?
Eligibility
Adults who:
- Are ages 18 - 60
- Are in good health
- Do not have a bleeding disorder
- Are at least 110 pounds
- Do not have an autoimmune disease(s)
- Are not pregnant
- Have not had cancer within the past 5 years
- Are not currently in an investigational study
- Are not taking medications to treat high blood pressure
What is Involved?
Description
If you choose to join this study, you will have 2 visits.
- You will have blood draws at both visits
- The first visit will measure safety labs
- The second visit will be 3 hours long for the leukapheresis procedure
Study Details
Full Title
EQA Proficiency Testing and Quality Control Leukapheresis Protocol
Principal Investigator
Thomas
Denny
Protocol Number
PRO00000873
Enrollment Status
Open to Enrollment